Advertisement
Research Article| Volume 59, ISSUE 3, P185-190, September 1998

Effects of thromboxane A2 antagonist on airway hyperresponsiveness, exhaled nitric oxide, and induced sputum eosinophils in asthmatics

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      We examined effects of a thromboxane A2 (TXA2) antagonist seratrodast on airway hyperresponsiveness, exhaled nitric oxide (NO), and eosinophils in induced sputum in 14 asthmatics. Subjects were administered 80 mg of seratrodast once a day for 4 weeks. Respiratory conductance (Grs) was measured by the forced oscillation method and airway responsiveness was evaluated as the inhaled dose of methacholine, which induced 35% decrease in Grs. Subjects breathed into a Teflon bag, and NO concentration in the bag was measured by a chemiluminescence analyzer. Induced sputum comprised the entire expectorate produced during a 20 min inhalation of 3% saline, and was analyzed for total and differential cell counts. Airway hyperresponsiveness was significantly decreased by seratrodast. By contrast, no differences in either exhaled NO or percentage of eosinophils in sputum were observed before or after seratrodast. We conclude that seratrodast may attenuate airway hyperresponsiveness, presumably by antagonizing TXA2 released from the inflamed airways.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Prostaglandins, Leukotrienes and Essential Fatty Acids
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • O'Byrne P.M
        • Fuller R.W
        The role of thromboxane A2 in the pathogenesis of airway hyperresponsiveness.
        Eur Respir J. 1989; 2: 782-786
        • Boushey H.A
        • Holtzman M.J
        • Sheller J.R
        • Nadel J.A
        Bronchial hyperreactivity.
        Am Rev Respir Dis. 1980; 121: 389-414
        • Juniper E.F
        • Frith P.A
        • Hargreave F.E
        Airway responsiveness to histamine and methacholine: relationship to minimum tretment to control symptoms of asthma.
        Thorax. 1981; 36: 575-579
        • Murray A.B
        • Ferguson A.C
        • Morrison B
        Airway responsiveness to histamine as a test for overall severity of asthma in children.
        J Allergy Clin Immunol. 1981; 68: 119-124
        • Moncada S
        • Vane J
        Pharmacology and endogenous role of prostaglandin endoperoxide, thromboxane A2 and prostacyclin.
        Pharmacol Rev. 1979; 30: 293-331
        • Aizawa H
        • Chung K.F
        • Leikauf G.D
        • Ueki I.F
        • Bethel R.A
        • O'Byrne P.M
        • Hirose T
        • Nadel J.A
        Significance of thromboxane generation in ozone-induced airway hyperresponsiveness in dogs.
        J Appl Physiol. 1985; 59: 1918-1923
        • Jones G.L
        • Saroea H.G
        • Watson R.M
        • O'Byrne P.M
        Effect of an inhaled thromboxane mimetic (U-46619) on airway function in human subjects.
        Am Rev Respir Dis. 1992; 145: 1270-1274
        • Chung K.F
        • Aizawa H
        • Becker A.B
        • Frick O
        • gold W.M
        • Nadel J.A
        Inhibition of antigen-induced airway hyperresponsiveness by thromboxane synthetase inhibitor (OKY-046) in allergic dogs.
        Am Rev Respir Dis. 1986; 134: 258-261
        • Kurokawa T
        • Matsumoto T
        • Ashida Y
        • Sasada R
        • Iwasa S
        Antagonism of the human thromboxane A2 receptor by an anti-asthmatic agent AA-2414.
        Biological & Pharmaceutical Bulletin. 1994; 17: 383-385
        • Liel N
        • Mais D.E
        • Halushka P.V
        Binding of a thromboxane A2/prostaglandin H2 agonist [3H]U46619 to washed human platelets.
        Prostaglandins. 1987; 33: 789-797
        • Ushikubi F
        • Okuma M
        • Kanaji K
        • Sugiyama T
        • Ogorochi T
        • Narumiya S
        • Uchino H
        Hemorrhagic thrombocytopathy with platelet thromboxane A2 receptor abnormality: defective signal transduction with normal binding activity.
        Thrombosis & Haemostasis. 1987; 57: 158-164
        • Takishima T
        • Hida W
        • Sasaki H
        • Suzuki S
        • Sasaki T
        Direct-writing recorder of the dose-response curves of the airway to methacholine.
        Chest. 1981; 80: 600-606
        • Okayama M
        • Yafuso N
        • Nogami H
        • Lin Y.-N
        • Horio S
        • Hida W
        • Inoue H
        • Takishima T
        A new method of inhalation challenge with propranolol: Comparison with methacholine-induced bronchoconstriction and role of vagal nerve activity.
        J Allergy Clin Immunol. 1987; 80: 291-299
        • Ishii M
        • Hida W
        • Suzuki S
        • Ichinose M
        • Sasaki H
        • Takishima T
        Comparison of intermittent and continuous inhalation provocation tests.
        Ann Allergy. 1989; 62: 223-228
        • Mitsuhashi M
        • Tajima K
        • Tokuyama K
        • Morikawa A
        • Kuroume T
        Application of a new direct-writing recorder divice, the ‘astograph’ to the evaluation of methacholine-induced bronchoconstriction in asthmatic children.
        J Asthma. 1984; 21: 89-95
        • Mochizuki H
        • Mitsuhashi M
        • Shigeta M
        • Tokuyama K
        • Tajima K
        • Morikawa A
        • Kuroume T
        Bronchial hyperresponsiveness in children with atopic and nonatopic asthma.
        J Asthma. 1987; 24: 75-80
        • Chung K.F
        Pharmacology of airway inflammation in asthma.
        Lung. 1990; 168 (Suppl): 132-141
        • O'Byrne P.M
        • Walters E.H
        • Gold B.D
        • Aizawa H
        • Fabbri L.M
        • Alpert S.E
        • Nadel J.A
        • Holtzman M.J
        Neutrophil depletion inhibits airway hyperresponsiveness induced by ozone exposure.
        Am Rev Respir Dis. 1984; 130: 214-219
        • Chung K.F
        • Aizawa H
        • Leikauf G.D
        • Ueki I.F
        • Evans T.W
        • Nadel J.A
        Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation.
        J Pharmacol Exp Ther. 1986; 236: 580-584
        • O'Byrne P.M
        • Leikauf G.D
        • Aizawa H
        • Bethel R.A
        • Ueki I.F
        • Holtzman M.J
        • Nadel J.A
        Leukotriene B4 induces airway hyperesponsiveness in dogs.
        J Appl Physiol. 1985; 59: 1941-1946
        • Hamberg M
        • Svensson J
        • Wakabayashi T
        • Samuelsson B
        Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.
        in: Proc Natl Acad Sci USA. 71. 1974: 345-349
        • Svensson J
        • Strandberg K
        • Tuvemo T
        • Hamberg M
        Thromboxane A2: effects on airway and vascular smooth muscle.
        Prostaglandins. 1977; 14: 425-436
        • Hamberg M
        • Svensson J
        • Samuelsson B
        Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
        in: Proc Natl Acad Sci USA. 72. 1975: 2994-2998
        • Higgs G.A
        • Moncada S
        • Salmon J.A
        • Seager K
        The source of thromboxane and prostaglandins in experimental inflammation.
        Br J Pharmacol. 1983; 79: 863-868
        • Matsumoto K
        • Aizawa H
        • Inoue H
        • Shigyo M
        • Takata S
        • Hara N
        Thromboxane causes airway hyperresponsiveness following neurogenic inflammation induced by cigarette smoke.
        J Appl Physiol. 1996; 81: 2358-2364
        • Chung K.F
        • Evans T.W
        • Graf P.D
        • Nadel J.A
        Modulation of cholinergic neurotransmission in canine airways by thromboxane mimetic U 46619.
        Eur J Pharmacol. 1985; 117: 373-375
        • Tamaoki J
        • Sekizawa K
        • Graf P.D
        • Nadel J.A
        Cholinergic neuromodulation by prostaglandin D2 in canine airway smooth muscle.
        J Appl Physiol. 1987; 63: 1396-1400
        • Shephard E.G
        • Malan L
        • Macfarlane C.M
        • Mouton W
        • Joubert J.R
        Lung function and plasma levels of thromboxane B2, 6-ketoprostaglandin F and β-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment.
        Br J Clin Pharmacol. 1985; 19: 459-470
        • Seltzer J
        • Bigby B.G
        • Stulbarg M
        • Holtzman M.J
        • Nadel J.A
        • Ueki I.F
        • Leikauf G.D
        • Goetzl E.J
        • Boushey H.A
        Ozone-induced changes in bronchial reactivity to methacholine and airway inflammation in humans.
        J Appl Physiol. 1986; 60: 1321-1326
        • Kirby J.G
        • Hargreave F.E
        • Cockroft D.W
        • O'Byrne P.M
        The effect of indomethacin on allergen-induced asthmatic responses.
        J Appl Physiol. 1989; 66: 578-583
        • Townley R.G
        • Ryo U.Y
        • Kolotkin B.M
        • Kang B
        Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects.
        J Allergy Clin Immunol. 1975; 56: 429-442
        • Spector S.L
        • Farr R.S
        A comparison of methacholine and histamine inhalations in asthmatics.
        J Allergy Clin Immunol. 1975; 56: 308-316